Abstract
In this review we summarize selected articles that have been published about immunosuppressive agents in the past year. These studies fall into three major categories: 1) use of pulse cyclophosphamide in autoimmune diseases other than systemic lupus erythematosus; 2) use of newer immunosuppressive agents such as cyclosporine and FK506 in a variety of rheumatic diseases; and 3) toxicity.
MeSH terms
-
Adult
-
Arthritis, Juvenile / drug therapy
-
Azathioprine / adverse effects
-
Azathioprine / therapeutic use
-
Behcet Syndrome / drug therapy
-
Child
-
Cladribine / therapeutic use
-
Cyclophosphamide / administration & dosage
-
Cyclophosphamide / therapeutic use
-
Cyclosporine / therapeutic use
-
Drug Therapy, Combination
-
Granulomatosis with Polyangiitis / drug therapy
-
Humans
-
Hydroxychloroquine / administration & dosage
-
Hydroxychloroquine / adverse effects
-
Hydroxychloroquine / therapeutic use
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects
-
Immunosuppressive Agents / therapeutic use*
-
Liver / drug effects
-
Liver / injuries
-
Lung / drug effects
-
Lung Injury
-
Lupus Erythematosus, Systemic / drug therapy
-
Methotrexate / administration & dosage
-
Methotrexate / adverse effects
-
Methotrexate / therapeutic use
-
Pemphigoid, Benign Mucous Membrane / drug therapy
-
Retina / drug effects
-
Tacrolimus / therapeutic use
-
Thalidomide / therapeutic use
Substances
-
Immunosuppressive Agents
-
Cladribine
-
Hydroxychloroquine
-
Thalidomide
-
Cyclosporine
-
Cyclophosphamide
-
Azathioprine
-
Tacrolimus
-
Methotrexate